Watch What Our Clients Say About Our Work

Greg Merrill photo

Greg Merrill, CEO and Co-Founder, Adaptive Phage Therapeutic

Adaptive Phage Therapeutics, a clinical stage company advancing bacteriophage to treat otherwise antibiotic-resistant bacterial infections, engaged Facility Logix for a small cGMP manufacturing facility, and again when the company embarked on a 50,000 square-foot phase two expansion. Watch Greg Merrill, CEO and co-founder, relate the rewarding journey.

Watch video
Greg Merrill photo

Greg Merrill, CEO and Co-Founder, Adaptive Phage Therapeutic

Adaptive Phage Therapeutics, a clinical stage company advancing bacteriophage to treat otherwise antibiotic-resistant bacterial infections, engaged Facility Logix for a small cGMP manufacturing facility, and again when the company embarked on a 50,000 square-foot phase two expansion. Watch Greg Merrill, CEO and co-founder, relate the rewarding journey.

Kurt Foreman photo

Kurt Foreman, President and CEO, Delaware Prosperity Partnership

Recruiting and retaining pharmaceutical and biotech companies in states or regions is a critical goal for organizations like the Delaware Prosperity Partnership. Watch Kurt Foreman, president and CEO, discuss why he has called on Facility Logix repeatedly for guidance and assistance not only in his current post but also in his service for economic development organizations elsewhere.

Watch video
Kurt Foreman photo

Kurt Foreman, President and CEO, Delaware Prosperity Partnership

Recruiting and retaining pharmaceutical and biotech companies in states or regions is a critical goal for organizations like the Delaware Prosperity Partnership. Watch Kurt Foreman, president and CEO, discuss why he has called on Facility Logix repeatedly for guidance and assistance not only in his current post but also in his service for economic development organizations elsewhere.

Michael Dombeck photo

Michael Dombeck, Chief Operating Officer, Arcellx, Inc

A leader in CAR-T technology, Arcellx is breaking ground in transformative cell engineering that is harnessing the immune system to clear tumors. When its expansive growth required expanded facilities, the company turned to Facility Logix. Watch what Michael Dombeck, Arcellx COO, has to say about the process and Facility Logix service.

Watch video
Michael Dombeck photo

Michael Dombeck, Chief Operating Officer, Arcellx, Inc

A leader in CAR-T technology, Arcellx is breaking ground in transformative cell engineering that is harnessing the immune system to clear tumors. When its expansive growth required expanded facilities, the company turned to Facility Logix. Watch what Michael Dombeck, Arcellx COO, has to say about the process and Facility Logix service.

Nick Fullenkamp photo

Nick Fullenkamp, Vice President of Corporate Development, Barinthus Biotherapeutics (formerly Vaccitech)

A clinical stage biopharmaceutical company, Barinthus Biotherapeutics (formerly Vaccitech) develops immunotherapies for infectious disease, oncology, and autoimmune diseases. The company chose Facility Logix on the basis of industry recommendations. Watch Nick Fullenkamp, vice president of corporate development, discuss the work experience and learn the three words he would use to describe Facility Logix.

Watch video
Nick Fullenkamp photo

Nick Fullenkamp, Vice President of Corporate Development, Barinthus Biotherapeutics (formerly Vaccitech)

A clinical stage biopharmaceutical company, Barinthus Biotherapeutics (formerly Vaccitech) develops immunotherapies for infectious disease, oncology, and autoimmune diseases. The company chose Facility Logix on the basis of industry recommendations. Watch Nick Fullenkamp, vice president of corporate development, discuss the work experience and learn the three words he would use to describe Facility Logix.

Ron Holtz photo

Ron Holtz, CFO, MaxCyte®, Inc.

A leader in the life sciences tool space, MaxCyte® provides the technology for cell engineering. When expansive growth required the company to double the size of its facility, Facility Logix was engaged. Watch Ron Holz, CFO, discuss how Facility Logix provided end-to-end service from design and construction all the way through relocation to the new facility.

Watch video
Ron Holtz photo

Ron Holtz, CFO, MaxCyte®, Inc.

A leader in the life sciences tool space, MaxCyte® provides the technology for cell engineering. When expansive growth required the company to double the size of its facility, Facility Logix was engaged. Watch Ron Holz, CFO, discuss how Facility Logix provided end-to-end service from design and construction all the way through relocation to the new facility.

Thomas Kaufman photo

Thomas Kaufman, Associate Vice President, United Therapeutics Corporation

A mission-driven company founded to discover a cure for lung and other life-threatening diseases, United Therapeutics continues to develop products to improve the quality of life for patients with life-threatening illness. Watch Thomas Kaufman, associate vice president, discuss how the long-term relationship with Facility Logix has benefited United Therapeutics.

Watch video
Thomas Kaufman photo

Thomas Kaufman, Associate Vice President, United Therapeutics Corporation

A mission-driven company founded to discover a cure for lung and other life-threatening diseases, United Therapeutics continues to develop products to improve the quality of life for patients with life-threatening illness. Watch Thomas Kaufman, associate vice president, discuss how the long-term relationship with Facility Logix has benefited United Therapeutics.